Zoetis' U.S. Sales Increase 10%

Animal health pharmaceutical company Zoetis (NYSE: ZTS  ) reported an 8% increase in overall sales this quarter, bringing $1.1 billion in revenue. U.S. revenue accounted for $495 million, 10% above the company's third quarter in 2012.

Zoetis CEO Juan Ramon Alaix was pleased with the company's progress and expressed particular satisfaction with "how we are meeting our commitments to customers, delivering financial results, and setting a solid foundation for our future."

Revenue was up, but Zoetis' net income suffered for the quarter, dropping from $162 million in Q3 2012 to $131 million, or $0.26 per diluted share, a 19% decrease. The drop was partly caused by a 7% increase in Zoetis' cost of sales, along with a 19% increase in the amount of money the company spent on research and development.

Going into the future, Alaix expects Zoetis to "continue to build on the commercial performance, innovative R&D, and reliable supply chain that have been critical to our success, while managing through all the changes that come with standing up a new company."


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2714042, ~/Articles/ArticleHandler.aspx, 10/22/2014 8:10:21 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement